- Advertisement -
- GLP-1 medications, commonly used for type 2 diabetes, were linked to a possible reduction in epilepsy risk, offering an encouraging early signal for researchers.
- Participants who used GLP-1 drugs were 16 percent less likely to develop epilepsy compared with those who took DPP-4…
